Company research
Chemomab Therapeutics Ltd.
CIK 1534248Updated Nov 15, 2026
SecurityCMMB · NASDAQ · adr
Historical securities (1)
BCNLF · OTC · equity · closed Apr 21, 2020Name history
Anchiano Therapeutics Ltd. · through Mar 17, 2021BioCancell Ltd. · through Nov 3, 2015
BCNLF price & chart
Historical security
This listing closed Apr 21, 2020. Live provider charts are shown only for current listings.
In the news
No coverage from other publishers is available.
Financials
FY 2025 · USDSource
Source
Source
Source
Source
balance sheet · annual statements
| Line item | Q3 2022 | Q3 2021 | Q2 2025 | Q2 2024 | Q2 2023 | Q2 2022 | Q1 2023 | Q1 2022 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||
| AssetsUSD | 50,219,000Source | 67,440,000Source | 11,129,000Source | 14,544,000Source | 28,849,000Source | 56,378,000Source | 35,013,000Source | 60,956,000Source | 13,812,000Source | 16,964,000Source | 22,151,000Source | 43,063,000Source |
| Property, Plant and Equipment, NetUSD | 380,000Source | 234,000Source | 217,000Source | 276,000Source | 338,000Source | 355,000Source | 352,000Source | 358,000Source | 176,000Source | 250,000Source | 303,000Source | 367,000Source |
| Current assets: | ||||||||||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 10,741,000Source | 37,744,000Source | 5,448,000Source | 5,036,000Source | 10,382,000Source | 9,883,000Source | 20,765,000Source | 13,827,000Source | 7,564,000Source | 6,071,000Source | 9,292,000Source | 13,519,000Source |
| Assets, CurrentUSD | 48,725,000Source | 65,842,000Source | 10,614,000Source | 13,455,000Source | 27,705,000Source | 54,830,000Source | 33,778,000Source | 59,340,000Source | 13,425,000Source | 16,040,000Source | 20,897,000Source | 41,736,000Source |
| Prepaid Expense and Other Assets, CurrentUSD | 2,259,000Source | 1,574,000Source | 1,101,000Source | 654,000Source | 1,042,000Source | 3,106,000Source | 995,000Source | 1,934,000Source | 3,059,000Source | 1,698,000Source | 1,037,000Source | 1,766,000Source |
| Operating Lease, Right-of-Use AssetUSD | 261,000Source | 359,000Source | 0Source | 341,000Source | 160,000Source | 295,000Source | 193,000Source | 309,000Source | 0Source | 289,000Source | 392,000Source | 227,000Source |
| LIABILITIES AND EQUITY | ||||||||||||
| LiabilitiesUSD | 5,595,000Source | 1,928,000Source | 1,430,000Source | 4,559,000Source | 6,858,000Source | 4,542,000Source | 7,059,000Source | 3,720,000Source | 1,478,000Source | 3,427,000Source | 5,154,000Source | 6,840,000Source |
| Stockholders’ equity: | ||||||||||||
| Common Stock, Value, IssuedUSD | 0Source | — | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source |
| Additional Paid in CapitalUSD | 100,171,000Source | 96,649,000Source | 117,702,000Source | 106,162,000Source | 103,751,000Source | 99,303,000Source | 101,744,000Source | 98,513,000Source | 123,952,000Source | 116,160,000Source | 105,675,000Source | 101,260,000Source |
| Retained Earnings (Accumulated Deficit)USD | -55,547,000Source | -31,137,000Source | -108,003,000Source | -96,177,000Source | -80,542,000Source | -47,467,000Source | -72,572,000Source | -41,277,000Source | -111,618,000Source | -102,623,000Source | -88,678,000Source | -63,819,000Source |
| Stockholders' Equity Attributable to ParentUSD | 44,624,000Source | 65,512,000Source | 9,699,000Source | 9,985,000Source | 21,991,000Source | 51,836,000Source | 27,954,000Source | 57,236,000Source | 12,334,000Source | 13,537,000Source | 16,997,000Source | 36,223,000Source |
| Liabilities and EquityUSD | 50,219,000Source | 67,440,000Source | 11,129,000Source | 14,544,000Source | 28,849,000Source | 56,378,000Source | 35,013,000Source | 60,956,000Source | 13,812,000Source | 16,964,000Source | 22,151,000Source | 43,063,000Source |
| Current liabilities: | ||||||||||||
| Liabilities, CurrentUSD | 5,477,000Source | 1,630,000Source | 1,430,000Source | 4,308,000Source | 6,825,000Source | 4,394,000Source | 6,997,000Source | 3,517,000Source | 1,478,000Source | 3,218,000Source | 4,838,000Source | 6,749,000Source |
| Operating Lease, Liability, CurrentUSD | 126,000Source | 61,000Source | 0Source | 109,000Source | 108,000Source | 132,000Source | 115,000Source | 116,000Source | 0Source | 115,000Source | 76,000Source | 123,000Source |
| Operating Lease, Liability, NoncurrentUSD | 118,000Source | 298,000Source | 0Source | 251,000Source | 33,000Source | 148,000Source | 62,000Source | 203,000Source | 0Source | 209,000Source | 316,000Source | 91,000Source |
| Additional Financial Items | ||||||||||||
| Accrued Liabilities, CurrentUSD | 2,577,000Source | 637,000Source | 666,000Source | 2,546,000Source | 2,503,000Source | 1,712,000Source | 3,164,000Source | 1,248,000Source | 337,000Source | 1,563,000Source | 3,423,000Source | 3,378,000Source |
| Cash, Cash Equivalents, and Short-term InvestmentsUSD | — | — | 9,500,000Source | — | — | — | — | — | 10,400,000Source | 14,300,000Source | — | — |
cash flow · annual statements
| Line item | Q4 2022 | Q3 2022 | Q2 2025 | Q2 2024 | Q2 2023 | Q2 2022 | Q1 2023 | Q1 2022 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | ||||||||||||
| Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD | — | — | — | — | — | — | -8,753,000Source | -5,104,000Source | -8,995,000Source | -13,945,000Source | -24,221,000Source | -27,646,000Source |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||||||
| Share-based Payment Arrangement, Noncash ExpenseUSD | — | — | — | — | — | — | 484,000Source | 874,000Source | 623,000Source | 617,000Source | 1,491,000Source | 3,211,000Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | — | — | — | — | — | — | -7,186,000Source | -3,711,000Source | -11,130,000Source | -15,386,000Source | -23,611,000Source | -20,370,000Source |
| Cash flows from investing activities: | ||||||||||||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | — | — | — | — | — | — | 14,432,000Source | 2,382,000Source | 5,390,000Source | 2,297,000Source | 15,879,000Source | 19,533,000Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | — | — | — | — | — | — | 1,000Source | 14,000Source | 3,000Source | 0Source | 3,000Source | 68,000Source |
| Cash flows from financing activities: | ||||||||||||
| Net Cash Provided by (Used in) Financing ActivitiesUSD | — | — | — | — | — | — | 0Source | 0Source | 7,157,000Source | 9,868,000Source | 3,504,000Source | -808,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | — | — | — | — | — | — | 7,246,000Source | -1,329,000Source | 1,417,000Source | -3,221,000Source | -4,228,000Source | -1,645,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | — | 10,818,000Source | 5,596,000Source | 5,110,000Source | 10,456,000Source | 9,960,000Source | 20,842,000Source | 13,912,000Source | 7,564,000Source | 6,147,000Source | 9,368,000Source | 13,596,000Source |
| Supplemental disclosure of cash flow information: | ||||||||||||
| Income Taxes Paid, NetUSD | — | — | — | — | — | — | — | — | — | — | — | 5,000Source |
| Additional Financial Items | ||||||||||||
| Share-based Payment Arrangement, ExpenseUSD | — | — | — | — | — | — | — | — | 623,000Source | 617,000Source | 1,491,000Source | 3,211,000Source |
| Cash, Cash Equivalents, and Short-term InvestmentsUSD | — | — | 9,500,000Source | — | — | — | — | — | 10,400,000Source | 14,300,000Source | — | — |
| DepreciationUSD | — | — | — | — | — | — | 16,000Source | 13,000Source | 70,000Source | 53,000Source | 67,000Source | 58,000Source |
| General and Administrative ExpenseUSD | — | 2,894,000Source | — | 840,000Source | 3,175,000Source | 3,340,000Source | 2,162,000Source | 2,575,000Source | 3,734,000Source | 3,412,000Source | 7,078,000Source | 11,556,000Source |
| Income Tax Expense (Benefit)USD | — | 0Source | — | 0Source | 34,000Source | -544,000Source | 21,000Source | 0Source | 0Source | 0Source | 0Source | -534,000Source |
| Net Income (Loss) Attributable to ParentUSD | — | -8,080,000Source | -2,057,000Source | -3,631,000Source | -7,970,000Source | -6,190,000Source | -8,753,000Source | -5,104,000Source | -8,995,000Source | -13,945,000Source | -24,221,000Source | -27,646,000Source |
| Nonoperating Income (Expense)USD | — | — | — | — | — | — | — | — | 572,000Source | 794,000Source | 1,238,000Source | 353,000Source |
| Operating ExpensesUSD | — | 8,317,000Source | — | 3,768,000Source | 8,195,000Source | 6,254,000Source | 9,049,000Source | 5,320,000Source | 9,567,000Source | 14,739,000Source | 25,459,000Source | 28,533,000Source |
| Operating Lease, Impairment LossUSD | — | — | — | — | — | — | — | — | — | — | 392,000Source | 17,000Source |
| Proceeds from Stock Options ExercisedUSD | — | — | — | — | — | — | — | — | 12,000Source | 0Source | 0Source | 143,000Source |
income statement · annual statements
| Line item | Q4 2022 | Q3 2022 | Q2 2025 | Q2 2024 | Q2 2023 | Q2 2022 | Q1 2023 | Q1 2022 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cost of Goods and Services Sold | — | — | — | — | — | — | — | — | —Source | —Source | —Source | — |
| Operating Income (Loss)USD | — | — | — | — | — | — | — | — | -112,000,000Source | -103,000,000Source | — | — |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | — | -8,080,000Source | — | -3,631,000Source | -7,936,000Source | -6,734,000Source | -8,732,000Source | -5,104,000Source | -8,995,000Source | -13,945,000Source | -24,221,000Source | -28,180,000Source |
| Income Tax Expense (Benefit)USD | — | 0Source | — | 0Source | 34,000Source | -544,000Source | 21,000Source | 0Source | 0Source | 0Source | 0Source | -534,000Source |
| Net Income (Loss) Attributable to ParentUSD | — | -8,080,000Source | -2,057,000Source | -3,631,000Source | -7,970,000Source | -6,190,000Source | -8,753,000Source | -5,104,000Source | -8,995,000Source | -13,945,000Source | -24,221,000Source | -27,646,000Source |
| Earnings Per Share, BasicUSD per share | — | 0.04Source | — | 0.01Source | 0.04Source | 0.03Source | 0.04Source | 0.02Source | 0.02Source | 0.04Source | 0.1Source | 0.12Source |
| Earnings Per Share, DilutedUSD per share | — | 0.04Source | — | 0.01Source | 0.04Source | 0.03Source | 0.04Source | 0.02Source | 0.02Source | 0.04Source | 0.1Source | 0.12Source |
| Weighted Average Number of Shares Outstanding, Basicshares | — | 228,773,418Source | — | 286,080,133Source | 221,674,130Source | 228,173,276Source | 220,996,240Source | 228,090,300Source | 510,227,715Source | 359,048,638Source | 234,998,859Source | 227,589,288Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | — | 228,773,418Source | — | 286,080,133Source | 221,674,130Source | 228,173,276Source | 220,996,240Source | 228,090,300Source | 510,227,715Source | 359,048,638Source | 234,998,859Source | 227,589,288Source |
| Additional Financial Items | ||||||||||||
| General and Administrative ExpenseUSD | — | 2,894,000Source | — | 840,000Source | 3,175,000Source | 3,340,000Source | 2,162,000Source | 2,575,000Source | 3,734,000Source | 3,412,000Source | 7,078,000Source | 11,556,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, DomesticUSD | — | — | — | — | — | — | — | — | 9,035,000Source | — | — | — |
| Income (Loss) from Continuing Operations, Per Basic ShareUSD per share | — | — | — | — | — | — | — | — | 0.02Source | 0.04Source | 0.1Source | 0.12Source |
| Income (Loss) from Continuing Operations, Per Diluted ShareUSD per share | — | — | — | — | — | — | — | — | 0.02Source | 0.04Source | 0.1Source | 0.12Source |
| Nonoperating Income (Expense)USD | — | — | — | — | — | — | — | — | 572,000Source | 794,000Source | 1,238,000Source | 353,000Source |
| Operating ExpensesUSD | — | 8,317,000Source | — | 3,768,000Source | 8,195,000Source | 6,254,000Source | 9,049,000Source | 5,320,000Source | 9,567,000Source | 14,739,000Source | 25,459,000Source | 28,533,000Source |
| Other General and Administrative ExpenseUSD | — | — | — | — | — | — | — | — | 142,000Source | 124,000Source | 323,000Source | 1,423,000Source |
| Research and Development ExpenseUSD | — | 5,423,000Source | — | 2,928,000Source | 5,020,000Source | 2,914,000Source | 6,887,000Source | 2,745,000Source | 5,833,000Source | 11,327,000Source | 18,381,000Source | 16,977,000Source |